SYRS
Syros Pharmaceuticals, Inc. - Common Stock (SYRS)
$03
About Syros Pharmaceuticals, Inc. - Common Stock (SYRS)
Syros Pharmaceuticals, Inc. engages in the development of gene control therapies for cancer and diseases. Its product candidates include SY-1425, SY-2101, and SY-5609. The company was founded by Richard A. Young, Nathanael S. Gray, and James E. Bradner on November 9, 2011 and is headquartered in Cambridge, MA.
Details
Daily high
$0.03
Daily low
$0.02
Price at open
$0.02
52 Week High
$6.93
52 Week Low
$0.02
Market cap
673,500
Dividend yield
0.00%
Volume
76,679
Avg. volume
152,824
P/E ratio
-.01
Syros Pharmaceuticals, Inc. - Common Stock News
Details
Daily high
$0.03
Daily low
$0.02
Price at open
$0.02
52 Week High
$6.93
52 Week Low
$0.02
Market cap
673,500
Dividend yield
0.00%
Volume
76,679
Avg. volume
152,824
P/E ratio
-.01